all of sudden Medications for Hypoprothrombinemia, Not Associated with Anticoagulant Therapy Medication List Q & A More What is Hypoprothrombinemia, Not Associated with Anticoagulant Therapy: Hypoprothrombinemia, Not Associated with Anticoagulant Therapy describes a condition where there is a deficiency of prothrombin in the blood which causes impaired clotting and an increased risk of bleeding and is not associated with anticoagulant therapy. Medications to treat Hypoprothrombinemia, Not Associated with Anticoagulant Therapy The following list of medications are in some way related to, or used in the treatment of this condition. Drug Class (show all) - vitamins (4) - anticoagulant reversal agents (4) Rx OTC Off Label Only Generics Drug name Rx / OTC Preg nancy CSA Alcohol Reviews Rating Popularity phytonadione Rx/OTC C N Add review Rate Generic name: phytonadione systemic Brand names: Mephyton, Vitamin K1, Aquamephyton Drug class: vitamins , anticoagulant reversal agents For consumers: dosage , interactions , side effects For professionals: A-Z Drug Facts , AHFS DI Monograph , Prescribing Information Mephyton Rx/OTC C N Add review Rate Generic name: phytonadione systemic Drug class: vitamins , anticoagulant reversal agents For consumers: dosage , interactions , side effects For professionals: Prescribing Information Vitamin K1 Rx/OTC C N Add review Rate Generic name: phytonadione systemic Drug class: vitamins , anticoagulant reversal agents For consumers: dosage , interactions , side effects For professionals: Prescribing Information Aquamephyton Rx/OTC C N Add review Rate Generic name: phytonadione systemic Drug class: vitamins , anticoagulant reversal agents For consumers: dosage , interactions , side effects For professionals: Prescribing Information Legend Off Label This medication may not be approved by the FDA for the treatment of this condition. Prescription Only / Over the Counter Rx Prescription Only OTC Over the Counter Rx/OTC Prescription or Over the Counter Pregnancy A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. N FDA has not classified the drug. Controlled Substances Act Schedule N Is not subject to the Controlled Substances Act. 1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. 2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. 3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. 4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. 5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. Alcohol X Interacts with Alcohol. Browse Drugs by Condition A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Help and Support Looking for answers? Ask a question or go join the hypoprothrombinemia, not associated with anticoagulant therapy support group to connect with others who have similar interests. sporting events
awakened Medications for Hypoprothrombinemia, Not Associated with Anticoagulant Therapy worrying
EmoticonEmoticon